Retatrutide titration calculator
Plan your retatrutide dose escalation based on the Eli Lilly Phase 2b trial protocol. Enter your current week to see where you are in the schedule.
Current dose (week 1)
1 mg
Once weekly subcutaneous injection
Full titration schedule
| Weeks | Dose | Phase |
|---|---|---|
| 1–4current | 1 mg | Escalation |
| 5–8 | 2 mg | Escalation |
| 9–12 | 4 mg | Escalation |
| 13–16 | 8 mg | Escalation |
| 17+ | 12 mg | Maintenance |
Based on Eli Lilly Phase 2b trial (NCT04881383). Escalation every 4 weeks.
Research use only. This calculator is provided for educational and research purposes only. It does not constitute medical advice. Consult a licensed physician before use.
References
1.
Jastreboff AM, Kaplan LM, Frías JP, et al. (2023). Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine. DOI: 10.1056/NEJMoa2301972